Bill Information for s1095-119

Long Title

A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition, and facilitate the efficient review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes.

Short Title

Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act

Vote Information

Status: REPORTED as of 2025-04-03 00:00:00.

Sponsor: This bill was sponsored by Amy Klobuchar (D-MN).

Party line votes are determined based on this being a D-sponsored piece of legislation. See here for information on how party line votes are determined.

Vote count: There were 0 roll call votes on this bill in total.